Iovance Biotherapeutics has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $211 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Iovance Biotherapeutics is raising $211,000,000.00 in new funding. About Iovance Biotherapeutics: Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy…